BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 27/02/2023

FDA Drafts Guidance for Industry on Treating Neovascular Age-Related Macular Degeneration with New Drugs

The FDA is releasing a draft guidance for pharmaceutical companies to develop effective treatments for neovascular age-related macular degeneration, outlining eligibility criteria, trial design, and efficacy endpoints to improve clinical trial data quality.

Source: Federal Register — Food and Drug AdministrationOpen original release →